Skip to content
NYSE: IGC
|
Borse Berlin: IGS1.BE
|
Frankfurt: IGS1
IGC
India Globalization Capital Inc.
Menu
Home
Life Sciences
Infrastructure Business
Investors
Press Releases
SEC Filings
Leadership
XBRL Files
Governance
IGC Form 8-K
June 13, 2022
June 13, 2022
by
Alejandro
Post navigation
← IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders
IGC Acquires Exclusive Rights for a Potential Alzheimer’s
Drug Development Candidate →